SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech
- Written by PR Newswire
- SanegeneBio grants exclusive worldwide license to one of its RNAi programs to Genentech
- SanegeneBio to receive $200 million upfront payment and will be eligible to receive development and commercialization milestone payments, totaling up to $1.5 billion, plus tiered royalties
- Genentech will be responsible for the subsequent clinical...
Read more: SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech














